AccueilPGEN • NASDAQ
add
Intrexon
1,35 $
Avant l'ouverture :(3,70 %)+0,050
1,40 $
Fermé : 8 mai, 08:40:16 UTC−4 · USD · NASDAQ · Clause de non-responsabilité
Dernière clôture
1,35 $
Plage sur l'année
0,65 $ - 2,17 $
Capitalisation boursière
397,05 M USD
Volume moyen
1,33 M
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
NASDAQ
Actualités des marchés
À propos
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Date de fondation
21 mai 1998
Site Web
Employés
143
